热灭活干酪乳杆菌DK128增强流感疫苗Th1免疫应答及保护效力
本研究在正常及CD4缺陷小鼠中评估热灭活干酪乳杆菌DK128对裂解流感疫苗的佐剂效应。结果显示DK128佐剂疫苗诱导更高IgG1和IgG2c抗体,单剂接种即可改善肺功能、减少体重丢失、加速病毒清除并降低炎症。CD4敲除小鼠中疫苗加DK128(而非单独疫苗)可诱导IgG类别转换并抵抗致死性攻击。
要点
- 热灭活DK128佐剂可显著提高裂解流感疫苗诱导的IgG1和IgG2c抗体水平。
- 单剂DK128佐剂疫苗在正常小鼠中增强保护:肺功能完整、体重丢失少、病毒清除快。
- CD4缺陷小鼠中DK128佐剂疫苗可诱导IgG类别转换并赋予致死性攻击保护。
核心结论
- 热灭活干酪乳杆菌DK128是潜在疫苗佐剂,可在CD4缺陷条件下促进IgG类别转换并增强裂解流感疫苗的保护效力。
研究设计与样本
- 研究使用正常小鼠和CD4 T细胞敲除(CD4KO)小鼠,比较裂解流感病毒疫苗单独或联合热灭活DK128免疫后的抗体应答和保护效果。
主要发现
- DK128佐剂疫苗诱导的IgG1和IgG2c抗体水平显著高于单独疫苗。
- 单剂DK128佐剂疫苗保护效果更高:肺功能完整、体重丢失更少、肺部病毒载量清除增强、炎症细胞因子和浸润降低。
- CD4KO小鼠中疫苗加DK128(而非单独疫苗)诱导类别转换的IgG抗体并抵抗致死性攻击。
临床怎么用
- 提示热灭活DK128可作为流感疫苗佐剂,尤其可能改善免疫缺陷宿主的疫苗应答。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lactic acid bacteria Lactobacillus casei DK128 isolated from fermented vegetable foods was suggested to stimulate innate immune responses. Here, we investigated whether heat-killed DK128 would exhibit adjuvant effects on enhancing the efficacy of influenza vaccination. Immunization of mice with split influenza virus vaccine in the presence of heat-killed DK128 induced significantly higher levels of both IgG1 and IgG2c isotype antibodies than those by vaccine only. A single dose DK128-adjuvanted influenza vaccination conferred higher efficacy of protection, as evidenced by intact lung function, less weight loss, enhanced clearance of lung viral loads, and lower levels of inflammatory cytokines and infiltrates. Immunization of CD4 T cell-knockout (CD4KO) mice with influenza vaccine and DK128, but not with vaccine alone, induced isotype-switched IgG antibodies and protection against lethal challenge in CD4KO mice. The results in this study suggest heat-killed DK128 as a potential vaccine adjuvant, promoting the induction of IgG isotype switching in CD4-deficient condition and enhancing protective efficacy of split influenza vaccination in immunocompromised and immune-competent subjects.
引用
- Jung YJ, Kim KH, Ko EJ, et al. Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice. Vaccine. 2020. PMID: 32674907. doi:10.1016/j.vaccine.2020.06.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。